Takehiro Tozuka

Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer

Tsukasa Hasegawa, Noriko Yanagitani, Hirofumi Utsumi et al. · Anticancer Research · 2019 · 39 citations · Full text

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors

Takehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto et al. · BMC Cancer · 2020 · 38 citations · Full text

Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment

Takehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto et al. · Lung Cancer · 2020 · 37 citations

Translational Medicine, Immunology, Pharmacology +7

Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis

Takehiro Tozuka, Teppei Sugano, Rintaro Noro et al. · Oxford Medical Case Reports · 2018 · 31 citations · Full text

Vasculitis, Autoimmune Disease, Granulocyte +15

Feasibility of next‐generation sequencing test for patients with advanced <scp>NSCLC</scp> in clinical practice

Ryo Ariyasu, Ken Uchibori, Hironori Ninomiya et al. · Thoracic Cancer · 2020 · 28 citations · Full text